• 1
    Martin-Carbonero L, Benhamou Y, Puoti M et al. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus–infected patients with chronic hepatitis C. A European Collaborative Study. Clin Infect Dis 2004; 38: 128133.
  • 2
    Rosenthal E, Poiree M, Pradier C et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients n France (Mortavic 2001 study). AIDS 2003; 17: 18031809.
  • 3
    National Institutes of Health. Management of hepatitis C 2002. NIH Consens State Sci Statements 2002; 19: 146,
  • 4
    Sherman M, Bain V, Villeneuve JP et al. The management of chronic viral hepatitis: a Canadian consensus conference 2004. Can J Gastroenterol 2004; 18: 715728.
  • 5
    Churchill D, Mann D, Coker R et al. Fatal hemorrhage following liver biopsy in patients with HIV infection. Genitourin Med 1996; 72: 6264.
  • 6
    Cadranel JF, Rufat P, Desgos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32: 477481.
  • 7
    Sulkowski M, Mehta S, Torbenson M, Moore R, Thomas D. Unexpected significant liver disease among HIV/HCV infected persons with minimal fibrosis on initial liver biopsy. 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2005 [Abstract 121].
  • 8
    Wai C-T, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518526.
  • 9
    Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 10691075.
  • 10
    Forn X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986992.
  • 11
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 12
    Sterling R, Lissen E, Clumeck N et al. Can routine non-invasive tests predict liver histology in HIV/HCV co-infection? Analysis of patients entering the AIDS PEGASYS Ribavirin International Co-infection Trial (APRICOT). 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2005 [Abstract 120].
  • 13
    Myers RP, Benhamou B, Imbert-Bismut F et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003; 17: 721725.